Pretoria, 11 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the falsified Ozempic products currently being sold on the market and online. SAHPRA has been informed of advertisements regarding unauthorised Ozempic/semaglutide-containing products that are being disseminated through radio stations and...
The SAHPRA Service Desk will be unavailable from Friday, 08 December 2023 until Monday, 11 December 2023 as the ICT team will be performing maintenance. During this time, users will be unable to send queries, lot release applications or respond to existing queries using the system. Users will be...
The establishment of the African Medicines Agency (AMA) will significantly contribute to the improvement of healthcare delivery across the continent and better overall health of African citizens. Africa continues to be a growing continent in many aspects. It is expected that the population of young Africans...
Pretoria, 06 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is currently conducting a Stakeholder Satisfaction Survey through an independent market research agency, MarkData (Pty) Ltd. SAHPRA has commissioned MarkData to conduct these surveys to better understand its effectiveness in implementing its regulatory...
SAHPRA offices will be closed for the festive season from 12:00 on Friday, 22 December 2023 and will re-open on Tuesday, 02 January 2024. Submissions to SAHPRA New Medicine, Variation, License, Renewal Applications Applications/submissions must reach SAHPRA by 14 December 2023 at 13:00 to allow for the administrative...
Pretoria, 06 November 2023 – The South African Health Products Regulatory Authority (SAHPRA) is urging patients, doctors, nurses, or pharmacists to play their part in reporting side effects using the MedSafety app. Reporting side effects is key to helping make medicines safer for the population...
Pretoria, 26 October 2023 – The South African Health Products Regulatory Authority (SAHPRA) currently has four (4) COVID-19 vaccines which are under review, the COMIRNATY Bivalent paediatric and adult vaccines, mRNA (COMIRNATY Bivalent Infant DTU vaccine), and non-mRNA vaccine Coviccine. SAHPRA has so far registered three...
Pretoria, 10 October 2023 –The South African Health Products Regulatory Authority (SAHPRA) participated in a Carte Blanche media interview on an ongoing investigation into the illicit bulk sale of codeine-based cough mixtures. This investigative report was broadcast on Sunday, 08 October 2023. The report relates to...
The South African Health Products Regulatory Authority (SAHPRA) commemorated “World Patient Safety Day” and “World Pharmacist Day” (observed annually on 17 and 25 September, respectively). The World Health Organization’s (WHO’s) theme for the 2023 World Patient Safety Day is "Engaging patients for patient safety", with...
Pretoria, 14 September 2023 –The South African Health Products Regulatory Authority (SAHPRA) was the host country for a robust and engaging African Union Smart Safety Surveillance (AU3S) in-person Steering Group Meeting held on 11 – 12 September 2023 in Cape Town. AU-3S is a flagship...
